INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Data sources
SEC FORM 41h ago
HOUSE PTR1h ago
SEC 13F1h ago
ROBINHOOD CHAIN1h ago
WA
Corporate insider

Williams Paul Anthony

SVP, Products BusinessCIK 0001961994

EDGAR filingsOpen in network
Disclosed transactions6
Buys / sells0 / 0
Max Insider Score21
Connections with evidence1

Disclosed transactions

ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
9
WA
Williams Paul AnthonySVP, Products Business
EBSEmergent BioSolutions Inc.
Tax withholding
F$5,552
694 sh
Jun 8, 2026Jun 10, 2026
traded Jun 8, 2026
+2dSEC FORM 4

Evidence

Verified connections

  • Insider ofevidence
    Emergent BioSolutions Inc.SVP, Products Business · Feb 10, 2026
21
WA
Williams Paul AnthonySVP, Products Business
EBSEmergent BioSolutions Inc.
Grant or award
A
—
100.1K sh
Apr 29, 2026
May 1, 2026
traded Apr 29, 2026
+2d
SEC FORM 4

Evidence

16
WA
Williams Paul AnthonySVP, Products Business
EBSEmergent BioSolutions Inc.
Tax withholding
F$79K
9,397 sh
Mar 5, 2026Mar 5, 2026
traded Mar 5, 2026
+0dSEC FORM 4

Evidence

17
WA
Williams Paul AnthonySVP, Products Business
EBSEmergent BioSolutions Inc.
Grant or award
A—
44.8K sh
Mar 3, 2026Mar 5, 2026
traded Mar 3, 2026
+2dSEC FORM 4

Evidence

16
WA
Williams Paul AnthonySVP, Products Business
EBSEmergent BioSolutions Inc.
Disposition to issuer
D$95K
8,655 sh
Feb 6, 2026Feb 10, 2026
traded Feb 6, 2026
+4dSEC FORM 4

Evidence

9
WA
Williams Paul AnthonySVP, Products Business
EBSEmergent BioSolutions Inc.
Tax withholding
F$11K
1,022 sh
Feb 6, 2026Feb 10, 2026
traded Feb 6, 2026
+4dSEC FORM 4

Evidence